Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high‐risk T‐cell lymphoblastic lymphoma? by Ken H. Young

Get full text

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response? by Zijun Y. Xu-Monette, Mingzhi Zhang, Jianyong Li, Ken H. Young, Ken H. Young

Get full text

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment by Qingqing Cai, Yu Fang, Ken H. Young

Get full text

HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy by Xin Wan, Ken H. Young, Ou Bai

Get full text

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets by Yi Miao, Yi Miao, L. Jeffrey Medeiros, Zijun Y. Xu-Monette, Jianyong Li, Ken H. Young, Ken H. Young

Get full text

Cross-talk between Myc and p53 in B-cell lymphomas by Li Yu, Tian-Tian Yu, Ken H. Young

Get full text

Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave by Xinfang Yu, Wei Li, Ken H. Young, Yong Li

Get full text

Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies by Rui-Fang Sun, Qian-Qian Yu, Ken H. Young

Get full text

RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics by Poonam R. Pandey, Ken H. Young, Dhiraj Kumar, Neeraj Jain

Get full text

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma by Yuyang Pang, Tingxun Lu, Zijun Y. Xu-Monette, Ken H. Young

Get full text

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma by Tingxun Lu, Jie Zhang, Zijun Y. Xu-Monette, Ken H. Young

Get full text

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognost... by Hanne Due, Rasmus Froberg Brøndum, Ken H. Young, Martin Bøgsted, Karen Dybkær

Get full text

Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma by Tiantian Yu, Zijun Y. Xu-Monette, Li Yu, Yong Li, Ken H. Young

Get full text

Correction: Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma by Tiantian Yu, Zijun Y. Xu-Monette, Li Yu, Yong Li, Ken H. Young

Get full text

Clinical and Immunological Effects of p53-Targeting Vaccines by Shan Zhou, Chunmei Fan, Chunmei Fan, Zhaoyang Zeng, Ken H. Young, Yong Li

Get full text

Corrigendum: Clinical and immunological effects of p53-targeting vaccines by Shan Zhou, Chunmei Fan, Chunmei Fan, Zhaoyang Zeng, Ken H. Young, Yong Li

Get full text

Mutant p53 as an Antigen in Cancer Immunotherapy by Navid Sobhani, Alberto D’Angelo, Xu Wang, Ken H. Young, Daniele Generali, Yong Li

Get full text

B-cell acute lymphoblastic leukemia/lymphoma in relapse presenting as a cervical mass: A case report and review of literature by Jamil Kazma, Cynae Johnson, Nitin Jain, Vasantha Lakshmi Gali, Ken H. Young, Amir A. Jazaeri

Get full text

Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma by Tiantian Yu, Zijun Y. Xu-Monette, Zijun Y. Xu-Monette, Anand Lagoo, Wen Shuai, Bangchen Wang, Jadee Neff, Luis F. Carrillo, Eric D. Carlsen, Eric D. Carlsen, Sergio Pina-Oviedo, Ken H. Young, Ken H. Young

Get full text

Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis by Wen Lei, Mixue Xie, Qi Jiang, Nengwen Xu, Ping Li, Aibin Liang, Ken H. Young, Wenbin Qian

Get full text